Company profile · Biotech & medical
Center Laboratories
晟德大藥廠股份有限公司 · 4123
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Center Laboratories manufactures western pharmaceuticals, specializing in oral liquid formulations such as syrups, suspensions, and solutions.[1]
The company focuses its therapeutic categories primarily on upper respiratory tract treatments, antipyretic analgesics, gastrointestinal medications, and central nervous system treatments including epilepsy, depression, schizophrenia, dementia, and Parkinson’s disease.[2]
In addition to manufacturing and selling its own products, it offers contract manufacturing and sales services for other manufacturers.[2]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$143m | +6.1% | -17.7% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$45m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | Center Laboratories, Inc. |
|---|---|
| Chinese name | 晟德大藥廠股份有限公司 |
| Stock code | 4123 (TPEx) |
| Industry | Biotech & medical |
| Founded | 04 Nov 1959 |
| Listed | 07 Oct 2003 |
| Paid-in capital | NT$8.1bn |
| Chairman | 王素琦 |
| President | 許瑞寶 |
| Headquarters | 7F.,NO.3-2 PARK ST., NANGANG DIST., TAIPEI CITY 115, TAIWAN (R.O.C.) |
| Website | https://www.centerlab.com.tw |
| Official business description | 西藥製造業 · 西藥批發業 · 西藥零售業 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 晟德大藥廠股份有限公司 · mops · retrieved 04 Nov 2026
- Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list